HRSV prefusion-F protein with Adju-Phos adjuvant induces long-lasting Th2-biased immunity in mice

Hai Li(National Institute for Viral Disease Control and Prevention), Wenbo Xu(Shenyang Institute of Automation), Hu Ren(National Institute for Viral Disease Control and Prevention), Yangzi Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Lei Cao(Chinese Academy of Sciences), Yan Zhang(Chinese Academy of Sciences)
PLoS ONE
January 31, 2022
10.1371/journal.pone.0262231
Cited by 3

Related Papers

A Novel Coronavirus from Patients with Pneumonia in China, 2019
|New England Journal of Medicine|2020|30.5k
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
|The Lancet|2020|12.6k
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
|Nature|2020|1.2k
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
|Cell|2020|802
Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial
|The Lancet|2016|202